Echo Therapeutics Waiting to Hear Back from FDA
On November 11th of this year, Echo Therapeutics Inc™, a transdermal medical device company based out of Franklin, Massachussetts, submitted their revolutionary Prelude SkinPrep System™ […]
echo therapeutics
Michael Bloomberg Proclaims “OneMedForum Days” in New York City
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
OneMedForum New York 2010 Successfully Brings Together Innovators and Investors
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Making Diabetes Less Painful to Deal With
Diabetes patients don’t always engage in the self-care needed to control the disease.
Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital
The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.
Echo Therapeutics: Positive Developments for Needle-Free Monitoring System
On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.
[Company Profile] Echo Therapeutics
Echo Therapeutics of Franklin, Mass., has developed the Symphony tCGM System, a needle-free, wireless system that allows patients to painlessly and accurately monitor their blood glucose levels around the clock.
Pantec Reports Success In Transdermal Patch Trials
Some patients fear injections so much that they avoid getting proper medical treatment, sometimes with life-threatening results. Transdermal patches, which administer drugs through the skin, could make the bite of the needle a mere unpleasant memory.